← SynDRA
LUSUTROMBOPAG
SynDRA canonical compound SYN0033275 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | MPL | THPO |
|---|
| Mechanism of action | thrombopoietin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- MPL AGONIST
- Thrombopoietin receptor agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- DRD1
- PTGS1
- PGR
- KCNH2
- ESR1
- DRD3
- HTR1A
- ADORA3
- CHRM2
- CHRM1
- SLC6A4
- SLC6A3
- SLC6A2
- ADORA1
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KDR
- ADRA1A
- HTR2B
- ACHE
- HRH3
- F2
- ADRA2A
- AR
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
ATC classes
- B02B · VITAMIN K AND OTHER HEMOSTATICS
Cross-references
Synonyms
- MULPLETA
- Mulpleta
- S 888711
- mulpleta
- RSC888711
- S-888711
- Mulpleo (previously lusutrombopag shionogi)
- UNII-6LL5JFU42F
- 6LL5JFU42F
- 2-Propenoic acid, Lusutrombopag [USAN:INN]
- SCHEMBL3062
- lusutrombopagum
- RefChem:56992
- B02BX07
- DTXCID001513519
- MFCD28502075
- Lusutrombopag [INN]
- Lusutrombopag [USAN:INN]
- Mulpleta (TN)
- Lusutrombopag (Standard)
- LusutrombopagS-888711
- LUSUTROMBOPAG [MI]
- LUSUTROMBOPAG [JAN]
- LusutrombopagS-888711?
- LUSUTROMBOPAG [USAN]
- C29H32Cl2N2O5S
- LUSUTROMBOPAG [WHO-DD]
- orb1296119
- SCHEMBL3062080
- Lusutrombopag (JAN/USAN/INN)
- SCHEMBL29376923
- GTPL10032
- CHEBI:136051
- BDBM430660
- LUSUTROMBOPAG [ORANGE BOOK]
- EX-A1290
- EBC-27360
- HY-19883R
Reported adverse events
Look up LUSUTROMBOPAG in the interactive SynDRA portal →